FIELD: biotechnology, molecular genetics and medicine.
SUBSTANCE: invention relates to biotechnology, molecular genetics and medicine. A kit for detecting RNA of coronaviruses SARS-CoV-2, SARS-CoV, MERS-CoV, HCoV-229E, HCoV-NL63, HCoV-OC43, HCoV-HKU1 by loop isothermal amplification (LIA) is described.
EFFECT: invention can be used to identify these representatives of the Coronaviridae family for clinical laboratory diagnosis of coronavirus infection or for research purposes.
1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TEST SYSTEM FOR DETECTION OF SARS-CoV-2 OF OMICRON LINE BY SINGLE-STEP POLYMERASE CHAIN REACTION WITH REVERSE TRANSCRIPTION | 2021 |
|
RU2772362C1 |
| PRIMER PANEL FOR SEQUENCING OF HUMAN SEASONAL CORONAVIRUS hCoV-HKU1, hCoV-NL63, hCoV-OC43, hCoV-229E | 2024 |
|
RU2837888C1 |
| AGENT FOR INHIBITION OF REPLICATION OF SARS-COV-2 VIRUS MEDIATED BY RNA INTERFERENCE | 2020 |
|
RU2733361C1 |
| SET OF OLIGONUCLEOTIDE PRIMERS AND FLUORESCENTLY LABELED PROBES FOR THE IDENTIFICATION OF HUMAN CORONAVIRUS SARS-COV-2 RNA BY ISOTHERMAL PCR WITH REAL-TIME HYBRIDIZATION-FLUORESCENCE DETECTION | 2021 |
|
RU2778855C1 |
| VACCINE COMPOSITION AGAINST COVID-19 | 2020 |
|
RU2743595C1 |
| PEPTIDE IMMUNOGENS USED AS COMPONENTS OF VACCINE COMPOSITION AGAINST COVID-19 | 2020 |
|
RU2743594C1 |
| PEPTIDE IMMUNOGENS AND VACCINE COMPOSITION AGAINST COVID-19 WITH THE USE OF PEPTIDE IMMUNOGENS | 2020 |
|
RU2743593C1 |
| SET FOR IDENTIFYING SARS-CoV-2 CORONAVIRUS | 2021 |
|
RU2765497C1 |
| CRISPR-Cas 12 SYSTEM FOR DETECTING SARS-CoV-2 VIRUS RNA IN ULTRA-LOW CONCENTRATIONS | 2021 |
|
RU2764023C1 |
| METHOD FOR DETECTING CDNA OF SARS-COV-2 CORONAVIRUS USING SYNTHETIC OLIGONUCLEOTIDE PRIMERS IN POLYMERASE CHAIN REACTION | 2020 |
|
RU2727054C1 |
